Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1753-1764

  Billerbeck, Eva ^a   Horwitz, Joshua A ^a   Labitt, Rachael N ^a   Donovan, Bridget M ^a   Vega, Kevin ^a   Budell, William C ^a   Koo, Gloria C ^b   Rice, Charles M ^a   Ploss, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HLA A ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR GAMMA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BIOLUMINESCENCE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; HEPATITIS C VIRUS; HEPATOTROPIC VIRUS INFECTION; HLA SYSTEM; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STRAIN DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS IMMUNITY; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; CHEMOTAXIS; GENES, MHC CLASS II; GENES, REPORTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS, VIRAL, ANIMAL; HETEROGRAFTS; HLA-A2 ANTIGEN; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LIVER; LYMPHOCYTE DEPLETION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 84881429352     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201518     Document Type: Article

References (36)

1. World Health Organization. 2008. Factsheet Hepatitis B. World Health Organization, Geneva, Switzerland.
2. World Health Organization. 2010. Factsheet Hepatitis C. World Health Organization, Geneva, Switzerland.
3. World Health Organization. 2009. Factsheet Malaria. World Health Organization, Geneva, Switzerland.
4. Dustin, L. B., and C. M. Rice. 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25: 71-99.
5. Shultz, L. D., F. Ishikawa, and D. L. Greiner. 2007. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7: 118-130.
6. Legrand, N., A. Ploss, R. Balling, P. D. Becker, C. Borsotti, N. Brezillon, J. Debarry, Y. de Jong, H. Deng, J. P. Di Santo, et al. 2009. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6: 5-9.
7. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174: 6477-6489.
8. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 106: 1565-1573.
9. Denton, P. W., and J. V. García. 2011. Humanized mouse models of HIV infection. AIDS Rev. 13: 135-148.
10. Mercer, D. F., D. E. Schiller, J. F. Elliott, D. N. Douglas, C. Hao, A. Rinfret, W. R. Addison, K. P. Fischer, T. A. Churchill, J. R. Lakey, et al. 2001. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7: 927-933.
11. Bissig, K. D., T. T. Le, N. B. Woods, and I. M. Verma. 2007. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc. Natl. Acad. Sci. USA 104: 20507-20511.
12. Washburn, M. L., M. T. Bility, L. Zhang, G. I. Kovalev, A. Buntzman, J. A. Frelinger, W. Barry, A. Ploss, C. M. Rice, and L. Su. 2011. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140: 1334-1344.
13. Willinger, T., A. Rongvaux, T. Strowig, M. G. Manz, and R. A. Flavell. 2011. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 32: 321-327.
14. Danner, R., S. N. Chaudhari, J. Rosenberger, J. Surls, T. L. Richie, T. D. Brumeanu, and S. Casares. 2011. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 6: e19826.
15. Suzuki, M., T. Takahashi, I. Katano, R. Ito, M. Ito, H. Harigae, N. Ishii, and K. Sugamura. 2012. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γ cnull mouse. Int. Immunol. 24: 243-252.
16. Shultz, L. D., Y. Saito, Y. Najima, S. Tanaka, T. Ochi, M. Tomizawa, T. Doi, A. Sone, N. Suzuki, H. Fujiwara, et al. 2010. Generation of functional human Tcell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc. Natl. Acad. Sci. USA 107: 13022-13027.
17. Strowig, T., C. Gurer, A. Ploss, Y. F. Liu, F. Arrey, J. Sashihara, G. Koo, C. M. Rice, J. W. Young, A. Chadburn, et al. 2009. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 206: 1423-1434.
18. Jaiswal, S., T. Pearson, H. Friberg, L. D. Shultz, D. L. Greiner, A. L. Rothman, and A. Mathew. 2009. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE 4: e7251.
19. Camacho, R. E., R. Wnek, P. Fischer, K. Shah, D. M. Zaller, A. Woods, N. La Monica, L. Aurisicchio, P. Fitzgerald-Bocarsly, and G. C. Koo. 2007. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1 01 transgene: a model of SCID-hu mouse for vaccine development. Exp. Hematol. 35: 1219-1230.
20. Camacho, R. E., R. Wnek, K. Shah, D. M. Zaller, R. J. O'Reilly, N. Collins, P. Fitzgerald-Bocarsly, and G. C. Koo. 2004. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenicNOD/scid mice. Cell. Immunol. 232: 86-95.
21. Woods, A., H. Y. Chen, M. E. Trumbauer, A. Sirotina, R. Cummings, and D. M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180: 173-181.
22. Billerbeck, E., W. T. Barry, K. Mu, M. Dorner, C. M. Rice, and A. Ploss. 2011. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3- expressing NOD-SCID IL2Rγ(null) humanized mice. Blood 117: 3076-3086.
23. Dorner, M., J. A. Horwitz, J. B. Robbins, W. T. Barry, Q. Feng, K. Mu, C. T. Jones, J. W. Schoggins, M. T. Catanese, D. R. Burton, et al. 2011. A genetically humanized mouse model for hepatitis C virus infection. Nature 474: 208-211.
24. Billerbeck, E., H. E. Blum, and R. Thimme. 2007. Parallel expansion of human virus-specific FoxP3- effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J. Immunol. 179: 1039-1048.
25. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gönczöl, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.
26. Bessis, N., F. J. GarciaCozar, and M. C. Boissier. 2004. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther. 11(Suppl 1): S10-S17.
27. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2: 545-550.
28. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
29. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
30. Onion, D., L. J. Crompton, D. W. Milligan, P. A. Moss, S. P. Lee, and V. Mautner. 2007. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 88: 2417-2425.
31. Breous, E., S. Somanathan, P. Bell, and J. M. Wilson. 2011. Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver. Gastroenterology 141: 348-357.e341-343.
32. Cerny, A., J. G. McHutchison, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95: 521-530.
33. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191: 1499-1512.
34. Crispe, I. N. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27: 147-163.
35. Crispe, I. N. 2012. Migration of lymphocytes into hepatic sinusoids. J. Hepatol. 57: 218-220.
36. Thomson, A. W., and P. A. Knolle. 2010. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10: 753-766.